amlodipine has been researched along with macitentan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baelde, HJ; Danser, AH; Kappers, MH; Lankhorst, S; Mathijssen, RH; Sleijfer, S; Smedts, FM; van den Meiracker, AH; van Esch, JH | 1 |
| He, H; Liu, HC; Liu, XQ; Zheng, YS; Zhou, XT | 1 |
2 other study(ies) available for amlodipine and macitentan
| Article | Year |
|---|---|
Treatment of hypertension and renal injury induced by the angiogenesis inhibitor sunitinib: preclinical study.
Topics: Acute Kidney Injury; Amlodipine; Angiogenesis Inhibitors; Animals; Blood Pressure; Disease Models, Animal; Drug Therapy, Combination; Endothelin A Receptor Antagonists; Follow-Up Studies; Glomerular Filtration Rate; Hypertension; Indoles; Pyrimidines; Pyrroles; Rats; Rats, Inbred WKY; Sulfonamides; Sunitinib; Treatment Outcome | 2014 |
PK/PD modeling based on NO-ET homeostasis for improving management of sunitinib-induced hypertension in rats.
Topics: Administration, Oral; Amlodipine; Animals; Antihypertensive Agents; Biomarkers; Blood Pressure; Endothelin-1; Homeostasis; Hypertension; Male; Models, Molecular; Nitric Oxide; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Wistar; Sulfonamides; Sunitinib | 2020 |